Avio Smart Market Stack Limited has announced the completion of a strategic equity investment worth INR 1 crore in Shree Naganarasimha Private Limited (SNN), marking a significant expansion into the agro and food products sector. The investment was disclosed under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Investment Details

The company has acquired substantial stake in the target entity through a carefully structured transaction:

Target Company Profile

Shree Naganarasimha Private Limited, incorporated on December 24, 2022, operates in the manufacturing and trading of agro and food products. The company is engaged in comprehensive food processing activities including:

• Processing, producing, mixing, packing, and preserving food products
• Manufacturing of processed foods, beverages, and dry foods
• Trading in health foods, protein foods, and agro foods
• Import and export of various food products and beverages
• Dealing in vegetables, fruits, and nutrient-based food items

Financial Performance

SNN has demonstrated impressive growth trajectory since its incorporation, showing consistent revenue expansion:

The company's turnover has grown significantly from INR 1.39 crore in FY23 to INR 11.48 crore in FY25, reflecting strong business momentum in the agro-food sector.

Strategic Rationale

The acquisition is designed to derive operational and financial synergies between both entities. The investment does not fall within related party transactions, and the promoter group has no existing interest in the target entity. This represents the first tranche of the investment, with remaining tranches to be completed according to the Shareholders' Agreement terms.

Regulatory Compliance

The transaction has been structured in full compliance with regulatory requirements, with no additional governmental or regulatory approvals needed for completion. The company has maintained transparency through proper disclosure under SEBI regulations, following previous intimations dated January 08, 2026, January 23, 2026, and February 16, 2026.

Avio Smart Market Stack Limited has significantly expanded its strategic partnership with Huwel Lifesciences, moving beyond their initial tuberculosis diagnostics focus to launch a comprehensive range of patented molecular diagnostic products across multiple healthcare segments in India. The expanded collaboration, announced through a regulatory filing under SEBI Regulation 30, builds upon their existing shareholders' agreement and positions both companies to address India's broader infectious disease diagnostics market.

Expanded Product Portfolio and Technology Platform

The enhanced partnership encompasses a diverse range of molecular diagnostic solutions developed by Huwel Lifesciences. The company has established itself as a fully indigenous diagnostics innovator with comprehensive in-house capabilities spanning research, assay development, and manufacturing within its own facilities.

Huwel's diagnostic solutions are designed to operate on open RT-PCR systems, enabling utilization of the extensive RT-PCR laboratory infrastructure deployed across India during the COVID-19 pandemic. This approach facilitates scalable testing without requiring significant new infrastructure investments.

Market Opportunity and Scale

The expanded collaboration targets India's substantial infectious disease diagnostics market, which represents one of the largest globally. The market scope extends well beyond the initial tuberculosis focus:

National health programs and institutional healthcare networks conduct tens of millions of diagnostic tests annually across these disease segments, creating substantial commercial opportunities for indigenous diagnostic solutions.

Technology Validation and Cost Advantages

Huwel's tuberculosis diagnostic platform has received comprehensive validation through a Health Technology Assessment conducted by the Department of Health Research under the Ministry of Health & Family Welfare. The assessment demonstrates significant cost advantages:

The platform's compatibility with existing RT-PCR infrastructure positions it for rapid deployment across government health programs, hospital networks, diagnostic laboratories, and private healthcare providers.

Strategic Partnership Structure

Under the collaboration framework, Avio Smart Market Stack Limited holds a minority stake in Huwel Lifesciences and maintains contractual entitlement to receive a defined share of net project revenues generated from orders secured through its institutional engagement efforts. ASMS will leverage its institutional relationships, digital infrastructure capabilities, and experience in executing large-scale programs to support go-to-market strategy and commercialization.

Management Outlook

Commenting on the expanded collaboration, Mr. Vidhyasagar Reddy, Managing Director of Avio Smart Market Stack Limited, stated: "India has a significant opportunity to strengthen its public health infrastructure through indigenous diagnostic innovation. Our collaboration with Huwel Lifesciences brings together advanced molecular diagnostic technologies and our institutional market access capabilities. By leveraging the extensive RT-PCR infrastructure established across the country during the pandemic, we aim to accelerate the availability of rapid, accurate, and affordable diagnostics for diseases such as tuberculosis, HIV, hepatitis, and other infectious conditions."

The partnership aligns with ASMS's broader strategic expansion into the high-growth health-tech sector while supporting the Government of India's "Make in India" initiative through indigenous diagnostic innovation. Over the coming years, both companies expect to introduce multiple diagnostic product lines across different disease segments, expanding healthcare access across India's institutional and private healthcare networks.